RGX-121

RegenxBio touts positive data for rare disease drug RGX-121
Clinical Trials Arena
Wed, 09/4/24 - 11:20 am
Regenxbio
RGX-121
clinical trials
Hunter Syndrome
RegenXBio gets FDA support for Hunter syndrome gene therapy's accelerated review filing—in 2024
Fierce Biotech
Wed, 08/3/22 - 10:58 am
Regenxbio
Hunter Syndrome
RGX-121
accelerated approval
FDA